Verifying…
Home / Medicines A–Z / Ketorolac

Ketorolac

Carefully consider the potential benefits and risks of ketorolac tromethamine and other treatment options before deciding to use ketorolac. Use the lo.

Prescription medicine Intramuscular Safety alerts on record

How to use Ketorolac

What the official label says. If a doctor prescribed it, follow the prescription. Your pack's leaflet comes first if it is different.

Serious warning: Ketorolac tromethamine, a nonsteroidal anti-inflammatory drug (NSAID), is indicated for the short-term (up to 5 days in adults) management of moderately severe acute pain that requires analgesia at the opioid level. Oral ketorolac tromethamine is indicated only as continuation treatment following intravenous or intramuscular dosing of ketorolac tromethamine, if necessary. …
Who it is for

Carefully consider the potential benefits and risks of ketorolac tromethamine and other treatment options before deciding to use ketorolac. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS ). Acute Pain in Adult Patients Ketorolac tromethamine is indicated for the short-term (≤5 days) management of moderately severe acute pain that requires analgesia at the opioid level, usually in a postoperative setting. Therapy should always be initiated with intravenous or intramuscular dosing of ketorolac tromethamine, and oral ketorolac tromethamine is to be used only as continuation treatment, if necessary. …

How to take it and how often
  • Carefully consider the potential benefits and risks of ketorolac tromethamine and other treatment options before deciding to use ketorolac tromethamine
  • Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals
  • In adults, the combined duration of use of intravenous or intramuscular dosing of ketorolac tromethamine and oral ketorolac tromethamine is not to exceed 5 days
  • In adults, the use of oral ketorolac tromethamine is only indicated as continuation therapy to intravenous or intramuscular dosing of ketorolac tromethamine
  • See package insert for ketorolac tromethamine tablets for transition from intravenous or intramuscular dosing of ketorolac tromethamine (single- or multiple-dose) to multiple-dose oral ketorolac tromethamine
  • Note: Oral formulation should not be given as an initial dose
  • Use minimum effective dose for the individual patient
  • Total duration of treatment in adult patients: the combined duration of use of intravenous or intramuscular dosing of ketorolac tromethamine and oral ketorolac tromethamine is not to exceed 5 days
  • KETOROLAC TROMETHAMINE INJECTION Ketorolac tromethamine injection may be used as a single or multiple dose on a regular or "prn" schedule for the management of moderately severe, acute pain that requires analgesia at the opioid level, usually in a postoperative setting
  • Hypovolemia should be corrected prior to the administration of ketorolac tromethamine (see WARNINGS – Renal Effects ). …
Talk to a doctor first if
  • (see also Boxed WARNING ) Ketorolac Tromethamine is contraindicated in patients with previously demonstrated hypersensitivity to ketorolac tromethamine
  • Ketorolac tromethamine is contraindicated in patients with active peptic ulcer disease, in patients with recent gastrointestinal bleeding or perforation and in patients with a history of peptic ulcer disease or gastrointestinal bleeding. …
Warnings

(See also Boxed WARNING .) The total combined duration of use of oral ketorolac tromethamine and intravenous or intramuscular dosing of ketorolac tromethamine is not to exceed 5 days in adults. Ketorolac tromethamine is not indicated for use in pediatric patients. The most serious risks associated with ketorolac tromethamine are: Gastrointestinal Effects – Risk of Ulceration, Bleeding and Perforation: Ketorolac tromethamine is contraindicated in patients with previously documented peptic ulcers and/or gastrointestinal (GI) bleeding. …

Possible side effects

Adverse reaction rates increase with higher doses of ketorolac tromethamine. Practitioners should be alert for the severe complications of treatment with ketorolac tromethamine, such as G.I. ulceration, bleeding and perforation, postoperative bleeding, acute renal failure, anaphylactic and anaphylactoid reactions and liver failure (see Boxed WARNING , WARNINGS , PRECAUTIONS , and DOSAGE AND ADMINISTRATION ). These NSAID-related complications can be serious in certain patients for whom ketorolac tromethamine is indicated, especially when the drug is used inappropriately. …

If you take too much

Symptoms and Signs Symptoms following acute NSAIDs overdoses are usually limited to lethargy, drowsiness, nausea, vomiting, and epigastric pain, which are generally reversible with supportive care. Gastrointestinal bleeding can occur. Hypertension, acute renal failure, respiratory depression and coma may occur, but are rare. Anaphylactoid reactions have been reported with therapeutic ingestion of NSAIDs, and may occur following an overdose. Treatment Patients should be managed by symptomatic and supportive care following a NSAIDs overdose. There are no specific antidotes. …

If you miss a dose

Take it when you remember, unless it is nearly time for the next dose. Then skip the missed one. Never take two doses at once to make up for it. Check your leaflet, as some medicines are different.

From the official U.S. FDA label for this active ingredient. Your pack may have a different strength, so always read its leaflet. If a doctor prescribed it, follow the prescription. Ask a pharmacist if you are unsure. Label dated 2022-10-12.

Brands around the world

Products with Ketorolac as the active ingredient. Names differ between countries.

Registered products

United States (FDA)

OmidriaPHENYLEPHRINE 10.16 mg/mL, KETOROLAC 2.88 mg/mL · Injection, Solution, Concentrate · Omeros Corporation
NDC 62225-600Label
Ketorolac TromethamineKETOROLAC TROMETHAMINE 10 mg/1 · Tablet, Film Coated · Redpharm Drug
NDC 67296-2230Label
Ketorolac TromethamineKETOROLAC TROMETHAMINE 30 mg/mL · Injection, Solution · Fresenius Kabi USA, LLC
NDC 76045-104Label
Ketorolac TromethamineKETOROLAC TROMETHAMINE 10 mg/1 · Tablet, Film Coated · Injecta Medcial LLC
NDC 87234-7695Label
Phenylephrine And KetorolacPHENYLEPHRINE 10.16 mg/mL, KETOROLAC 2.88 mg/mL · Injection, Solution, Concentrate · Hospira, Inc.
NDC 0662-0600Label

Nigeria (NAFDAC)

NAFDACKetorolac Injection C4-1843NAFDACKetorolac Tromethamine Dispersible 10 mg Tablets_ A4-101599NAFDACKetolac Tablet A4-2833NAFDACKetolac Injection A4-2832NAFDACPanache Injection B4-9056NAFDACDolac-30 Injection## (pack size) A4-2742

Other countries: check your pack's registration number and we point you to your regulator.

Safety alerts and recalls

R.E.C.K. (Ropivacaine HCl, EPINEPHrine, CloNIDine HCl, and Ketorolac Tromethamine) in Sodium Chloride Solution, Total Volume: 50 mL syringe. INJECTION FOR PERIARTICULAR USE; Not foU.S. FDA Class II
10 Oct 2025 · QuVa Pharma, Inc. · OngoingPresence of Particulate Matter
Ketorolac Tromethamine Injection, USP, 60 mg/2 mL (30 mg/mL), 2 mL Single-Dose Vial, For Intramuscular Use Only, Rx only, Mfd. for: Camber Pharmaceuticals, Inc., Piscataway, NJ 088U.S. FDA Class II
1 Oct 2025 · Aspiro Pharma Limited · OngoingPresence of Particulate Matter: Particulate matter identified as glass
Ketorolac Tromethamine Ophthalmic Solution, 0.5%, 5 mL, Rx Only, Sterile, Manufactured by: Apotex Inc., Richmond Hill, Ontario, Canada, L4C 5H2, Manufactured for: Apotex Corp., WesU.S. FDA Class II
5 Sep 2025 · Apotex Corp. · OngoingLack of Assurance of Sterility; atypical weight loss due to improper bottle sealing leading to potential sterility concerns
Ketorolac Tromethamine Ophthalmic Solution, 0.5%, 10 mL, Rx Only, Manufactured by: Apotex Inc., Toronto, Ontario, Canada, M9L 1T9, Manufactured for: Apotex Corp., Weston, FL 33326,U.S. FDA Class II
28 May 2025 · Apotex Corp. · OngoingLack of Assurance of Sterility

A recall usually affects certain batches only. Compare the lot number on your pack.

Check your pack of Ketorolac

Or take photos of the pack
3 free checks left today Official sources: U.S. FDA · EMA (EU) · NAFDAC · WHO alerts

Questions about Ketorolac

What is Ketorolac used for?

Carefully consider the potential benefits and risks of ketorolac tromethamine and other treatment options before deciding to use ketorolac. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS ). Acute Pain in Adult Patients Ketorolac tromethamine is indicated for the short-term (≤5 days) management of moderately severe acute pain that requires analg (From the official U.S. FDA label.)

How do I take Ketorolac?

Follow your prescription or the leaflet in your pack. The official label says: Carefully consider the potential benefits and risks of ketorolac tromethamine and other treatment options before deciding to use ketorolac tromethamine. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals. In adults, the combined duration of use of intravenous or intramuscular dosing of ketorolac tromethamine and oral ketor…

Do I need a prescription for Ketorolac?

Usually yes. Ketorolac is a prescription medicine in most countries. Rules differ by country.

What brands contain Ketorolac?

Ketorolac is sold under names such as Acular, Omidria, Acuvail, Sprix, Ketorolac Tromethamine. Brand names differ between countries.

How can I check that my Ketorolac is genuine?

Scan the registration number on your pack with PillVera (NAFDAC number in Nigeria, NDC in the United States, DIN in Canada), check the expiry date and buy only from licensed pharmacies.